These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 12447672

  • 21. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K, Gazdar AF, Albores-Saavedra J, Kokkinakis DM.
    Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
    [Abstract] [Full Text] [Related]

  • 22. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M, Nagai H, Kamiakito T, Kawata H, Takayashiki N, Saito K, Tanaka A.
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
    Komori T, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, Nakaizumi A, Uehara H, Tanaka S, Mano Y, Kasugai T.
    Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
    [Abstract] [Full Text] [Related]

  • 25. [Pathology of intraductal papillary-mucinous tumor of the pancreas].
    Nobukawa B, Suda K, Yamasaki S, Takase M, Fukumura Y, Shiono S.
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489
    [Abstract] [Full Text] [Related]

  • 26. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.
    Oncol Rep; 2003 Jun; 10(1):21-5. PubMed ID: 12469138
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y, Yanagisawa A, Shimada M, Hidaka E, Seki M, Tada Y, Harada T, Saisho H, Kato Y.
    Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
    [Abstract] [Full Text] [Related]

  • 29. Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics.
    Fukushima N, Fukayama M.
    J Hepatobiliary Pancreat Surg; 2007 Jul; 14(3):238-42. PubMed ID: 17520198
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Molecular factors promoting carcinogenesis and malignant behavior of intraductal papillary mucinous tumors].
    Ichikawa Y, Ueda M, Miura Y, Kunihiro S, Ishikawa T, Endo I, Sekido H, Shimada H.
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):443-6. PubMed ID: 12854490
    [Abstract] [Full Text] [Related]

  • 32. Fine-needle aspiration cytology of mucinous tumors of the pancreas.
    Recine M, Kaw M, Evans DB, Krishnamurthy S.
    Cancer; 2004 Apr 25; 102(2):92-9. PubMed ID: 15098253
    [Abstract] [Full Text] [Related]

  • 33. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N.
    Pancreas; 2006 Apr 25; 32(3):281-7. PubMed ID: 16628084
    [Abstract] [Full Text] [Related]

  • 34. Clinicopathologic study of intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Tanaka M, Sawai H, Okada Y, Yamamoto M, Funahashi H, Takeyama H, Manabe T.
    Hepatogastroenterology; 2006 Apr 25; 53(71):783-7. PubMed ID: 17086889
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J, Niu J, Li M, Chiao PJ, Tsao MS.
    Cancer Res; 2005 Jun 15; 65(12):5045-53. PubMed ID: 15958547
    [Abstract] [Full Text] [Related]

  • 37. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?
    Wada K, Takada T, Yasuda H, Amano H, Yoshida M, Sugimoto M, Irie H.
    J Gastrointest Surg; 2004 Jun 15; 8(3):289-96. PubMed ID: 15019925
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM.
    Pathology; 2003 Feb 15; 35(1):14-24. PubMed ID: 12701679
    [Abstract] [Full Text] [Related]

  • 40. Where and when does pancreatic carcinoma start?
    Lüttges J, Hahn S, Klöppel G.
    Med Klin (Munich); 2004 Apr 15; 99(4):191-5. PubMed ID: 15085289
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.